HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $25 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:SLDB) with a Buy and maintains $25 price target.